GCC Cardiac Rhythm Management Devices Market

GCC Cardiac Rhythm Management Devices Market Size and Share:

The GCC cardiac rhythm management devices market size was valued at USD 566.61 Million in 2024. Looking forward, IMARC Group estimates the market to reach USD 1,025.23 Million by 2033, exhibiting a CAGR of 6.30% from 2025-2033. The significant rise in the incidence of cardiovascular diseases, especially arrhythmias, coronary artery disease, and heart failure; increasing investments in hospital infrastructure, state-of-the-art medical equipment, and digital health technologies; and heightened focus on positive healthcare policies, funding programs, and regulatory changes are expanding the GCC cardiac rhythm management devices market share.

The GCC market for cardiac rhythm management (CRM) devices is growing noticeably, with healthcare systems constantly augmenting their capacities to deal with the rising case load of cardiovascular disease. The Qatar, United Arab Emirates, and Saudi Arabia governments are heavily funding healthcare infrastructure, and public and private hospitals are adopting cutting-edge technologies to enhance cardiac care services. Consequently, the need for CRM devices like implantable cardioverter defibrillators (ICDs), pacemakers, and cardiac resynchronization therapy (CRT) devices, is increasing throughout the region. The producers are actively releasing next-generation CRM devices that include wireless connectivity, remote monitoring, and enhanced battery life.

At the same time, healthcare professionals are receiving ongoing training to remain familiar with the new technologies and procedural methods in cardiac rhythm management. Patients in the GCC are increasingly realizing the advantages of early detection and treatment of arrhythmias, thus driving the adoption of CRM devices. Governments are encouraging screening programs and awareness programs, which are motivating patients to undergo timely medical treatments. The favorable reimbursement policies and regulatory support are also increasing the pace of market entry of innovative medical technologies. Overall, the GCC's CRM devices market is fast evolving, driven by technological developments, increasing investments in the healthcare sector, and a proactive stance toward cardiovascular condition management across the region.

GCC Cardiac Rhythm Management Devices Market Trends:

Rising Prevalence of Cardiovascular Diseases

The GCC region is witnessing a significant rise in the incidence of cardiovascular diseases, especially arrhythmias, coronary artery disease, and heart failure. An increase is mainly attributed to sedentary lifestyles, high levels of obesity, diabetes, and hypertension, which are prevalent in the region. Healthcare professionals are countering this by improving diagnostic and treatment capabilities, and cardiologists are increasingly prescribing cardiac rhythm management (CRM) devices to treat these conditions. Hospitals are also acquiring sophisticated diagnostic equipment that is detecting rhythm disorders at early stages, thus demanding more CRM solutions. Healthcare bodies and governments are carrying out awareness campaigns to make the general public alert of the dangers of untreated heart conditions, encouraging early diagnosis and active treatment. With the increasing number of patients needing timely medical care, the implantation of devices like cardiac resynchronization therapy (CRT) systems, pacemakers, and implantable cardioverter-defibrillators (ICDs) is constantly increasing. The IMARC Group predicts that the GCC implantable medical devices market size is projected to attain USD 2.8 Billion by 2033.

Expanding Healthcare Infrastructure and Technological Integration

Healthcare systems in the GCC are rapidly modernizing with governments investing heavily in hospital infrastructure, state-of-the-art medical equipment, and digital health technologies, thereby impelling the GCC cardiac rhythm management devices market growth. In 2024, Saudi Arabia, a major country in the GCC region, ranked 32^nd in the World Index of Healthcare Innovation. Public and private healthcare facilities are equipping their cardiology departments with state-of-the-art CRM devices that provide enhanced accuracy, safety, and patient outcomes. In parallel, hospitals are adopting digital platforms that enable telemedicine and remote monitoring, which permit ongoing cardiac surveillance in the outpatient realm. These technologies are facilitating real-time optimization of treatments by clinicians and the prompt intervention of abnormal heart rhythms. Training is being upgraded to make medical staff familiar with using the most advanced CRM devices. The expanding focus on embracing minimally invasive treatments and customized care is also following suit with the enhanced utilization of smaller and smart CRM devices. As infrastructure transforms continuously, the region is becoming a technology-driven cardiac care hub.

Supportive Government Policies and Regulatory Environment

GCC governments are actively fostering the development in the market through positive healthcare policies, funding programs, and regulatory changes. National health plans are giving high priority to the prevention of non-communicable diseases, particularly cardiovascular disease, through encouraging early screening and investment in leading medical technology. Regulatory authorities are simplifying the approval process for new CRM devices, facilitating quicker entry and uptake. Meanwhile, governments are providing subsidies, grants, and collaborations with the private healthcare providers to enhance cardiac care services. Health authorities also launch collaborations with global medical device companies to implement advanced CRM technologies in local markets. These policy initiatives are promoting a more efficient, affordable, and accessible health system. In 2025, the Abu Dhabi Global Health Week (ADGHW) is organized under the sponsorship of His Highness Sheikh Khaled bin Mohamed bin Zayed Al Nahyan, Crown Prince of Abu Dhabi and Chairman of Abu Dhabi Executive Council. It is rapidly becoming a world convening destination for health and technology leaders to reimagine the future.

GCC Cardiac Rhythm Management Devices Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the GCC cardiac rhythm management devices market, along with forecasts at the regional and country levels from 2025-2033. The market has been categorized based on product, application, and end user.

Analysis by Product:

• Pacemakers
• Defibrillators
• Cardiac Resynchronization Therapy (CRT)

Defibrillators hold 47.8% of the market. Physicians and other healthcare professionals are increasingly adding new defibrillator technologies to their treatment options to manage the increasing incidence of sudden cardiac death and other life-threatening arrhythmias. Implantable cardioverter defibrillators (ICDs) and external defibrillators are both gaining prominence, as hospitals and emergency medical services increase their capabilities in cardiac care. Manufacturers are launching next-generation defibrillators with improved battery life, wireless connectivity, and automated features that are enhancing response time and treatment accuracy. According to GCC cardiac rhythm management devices market forecast, public health authorities are expected to encourage the installation of automated external defibrillators (AEDs) in public places to enhance emergency response.

Analysis by Application:

• Bradycardia
• Tachycardia
• Heart Failure
• Others

Tachycardia represents the largest segment. It is becoming a significant application segment in the cardiac rhythm management devices market in the GCC region, as healthcare systems are actively working to address the increasing prevalence of abnormal heart rhythms. Physicians are increasingly diagnosing different sorts of tachycardia, such as atrial fibrillation, supraventricular tachycardia, and ventricular tachycardia, which are increasingly becoming common due to lifestyle risk factors and chronic diseases, such as hypertension and diabetes. Hospitals and cardiology centers are constantly employing implantable and external devices to treat and monitor these arrhythmias efficiently. Sophisticated pacemakers and ICDs are being employed to identify and respond to fast heart rhythms in real time, curtailing the risk of serious cardiac events. At the same time, patient awareness is growing via public health campaigns, promoting early diagnosis and device-based therapy, thereby offering a favorable GCC cardiac rhythm management devices market outlook.

Analysis by End User:

• Hospital
• Home Care Settings
• Ambulatory Care Settings

Hospital holds the biggest market share as it is constantly being upgraded to provide sophisticated cardiac care. Tertiary care facilities and specialized cardiology hospitals are embracing cutting-edge CRM devices, such as pacemakers and cardiac resynchronization therapy (CRT) systems, to cure a variety of arrhythmias and heart failure conditions. Medical institutions are investing in the state-of-the-art cardiac units equipped with the latest monitoring and therapeutic technologies to improve treatment accuracy and patient outcomes. Healthcare professionals at the hospital level are getting specialized education to effectively employ these technologies, guaranteeing high clinical standards of care. At the same time, hospitals are partnering with international device manufacturers to integrate remote monitoring platforms that enable real-time data exchange and patient care.

Country Analysis:

• Saudi Arabia
• UAE
• Qatar
• Kuwait
• Oman
• Bahrain

Saudi Arabia holds 46.7% of the market share. The country is undergoing a tremendous increase in the adoption of cardiac rhythm management (CRM) devices because of the rising number of cardiovascular diseases and greater investments in healthcare. There is a steady infrastructure upgradation going on in hospitals and cardiac centers throughout the country along with the incorporation of advanced CRM technologies like cardiac resynchronization therapy (CRT) devices. Governing agencies are actively backing these developments with Vision 2030, which is encouraging modernization of the health sector and facilitating public-private partnerships. According to an article published by the International Trade Administration in 2024, in Vision 2030, the Saudi Arabian Government is projected to spend more than $65 billion for building the nation's healthcare infrastructure, restructure and privatize insurance and health services, initiate 21 "health clusters" nationwide, and broaden the delivery of e-health services. It also estimates growing private sector contribution to 65 percent from 40 percent by 2030, with the target of privatizing 2,300 primary health centers and 290 hospitals.

Competitive Landscape:

Key companies in the GCC market are aggressively pursuing strategic initiatives aimed at enhancing their business footprint and responding to increasing regional demand. Key manufacturers are constantly investing in research and development (R&D) aimed at developing next-generation CRM devices that provide improved functionality, including remote monitoring, longer battery life, and artificial intelligence (AI)-based diagnostics. All these innovations are helping healthcare providers enhance patient care and alleviate the burden on hospital infrastructure. Meanwhile, firms are extending regional distribution chains and forging partnerships with local healthcare centers to enhance access and uptake of sophisticated CRM solutions. Training sessions and workshops are being organized to assist cardiologists and doctors in making best use of new technology. Competitors are also joining government auctions and matching product lines with national healthcare strategies.

The report provides a comprehensive analysis of the competitive landscape in the GCC cardiac rhythm management devices market with detailed profiles of all major companies, including:

• Schiller Americas, Inc.
• Medtronic
• Abbott
• BIOTRONIK SE & Co. KG
• General Electric
• Osypka Medical
• Stryker
• BTL Industries

Latest News and Developments:

• January 2024: Abott Medical unveiled its latest pacemaker, which is only 38 millimeters and has a battery life of up to 25 years and is highly popular in the UAE. It can be implanted without any surgery or wires.
• January 2024: The Cardiac Catheterisation Laboratory at Sohar Hospital, with the assistance from the National Centre for Cardiac Medicine and Surgery, completed 42 pacemaker implants after its inauguration in February 2023.

GCC Cardiac Rhythm Management Devices Market Report Scope:

Key Benefits for Stakeholders:

• IMARC’s report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the GCC cardiac rhythm management devices market from 2019-2033.
• The research study provides the latest information on the market drivers, challenges, and opportunities in the GCC cardiac rhythm management devices market.
• Porter's Five Forces analysis assists stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the GCC cardiac rhythm management devices industry and its attractiveness.
• Competitive landscape allows stakeholders to understand their competitive environment and provides an insight into the current positions of key players in the market.